Literature DB >> 20219905

Translation control by protein kinase R restricts minute virus of mice infection: role in parvovirus oncolysis.

Iván Ventoso1, Juan J Berlanga, José M Almendral.   

Abstract

The relevance of translational control in the gene expression and oncotropism of the autonomous parvoviruses was investigated with MVMp, the prototype strain of minute virus of mice (MVM), infecting normal and transformed rodent and human cells of different tissue origins. Mouse embryo fibroblasts (MEFs) and NIH 3T3 fibroblasts were resistant to MVMp infection, but 3T3 fibroblasts derived from double-stranded RNA (dsRNA)-dependent protein kinase R (PKR) knockout mice (PKR(o/o)) behaved in a manner that was highly permissive to productive MVMp replication. NIH 3T3 resistance correlated with significant phosphorylation of eukaryotic translation initiation factor 2 (eIF2) occurring at early time points after infection. Permissive PKR(o/o) cells were converted to MVMp-restrictive cells after reintroduction of the PKR gene by transfection. Conversely, regulated expression of the vaccinia virus E3 protein, a PKR inhibitor, in MEFs prevented eIF2alpha phosphorylation and increased MVMp protein synthesis. In vitro-synthesized genome-length R1 mRNA of MVMp was a potent activator of PKR. Virus-resistant primary MEFs and NIH 3T3 cells responded to MVMp infection with significant increases in eIF2alpha phosphorylation. In contrast, virus-permissive mouse (PKR(o/o), BHK21, and A9) and human transformed (NB324K fibroblast, U373 glioma, and HepG2 hepatoma) cells consistently showed no significant increase in the level of eIF2alpha phosphorylation following MVMp infection. The synthesis of the viral NS1 protein was inversely correlated with the steady-state PKR levels. Our results show that the PKR-mediated antiviral response is an important mechanism for control of productive MVMp infection, and its impairment in human transformed cells allowed efficient MVMp gene expression. PKR translational control may therefore contribute to the oncolysis of MVMp and other autonomous parvoviruses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20219905      PMCID: PMC2863853          DOI: 10.1128/JVI.02188-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  79 in total

1.  A beta-stranded motif drives capsid protein oligomers of the parvovirus minute virus of mice into the nucleus for viral assembly.

Authors:  E Lombardo; J C Ramírez; M Agbandje-McKenna; J M Almendral
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

Review 2.  IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors.

Authors:  Kenya Honda; Tadatsugu Taniguchi
Journal:  Nat Rev Immunol       Date:  2006-09       Impact factor: 53.106

Review 3.  Type I interferons in host defense.

Authors:  Daniel B Stetson; Ruslan Medzhitov
Journal:  Immunity       Date:  2006-09       Impact factor: 31.745

4.  Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus.

Authors:  D F Stojdl; B Lichty; S Knowles; R Marius; H Atkins; N Sonenberg; J C Bell
Journal:  Nat Med       Date:  2000-07       Impact factor: 53.440

5.  Antiviral effect of the mammalian translation initiation factor 2alpha kinase GCN2 against RNA viruses.

Authors:  Juan J Berlanga; Iván Ventoso; Heather P Harding; Jing Deng; David Ron; Nahum Sonenberg; Luis Carrasco; César de Haro
Journal:  EMBO J       Date:  2006-04-06       Impact factor: 11.598

6.  Positive and negative effects of adenovirus type 5 helper functions on adeno-associated virus type 5 (AAV5) protein accumulation govern AAV5 virus production.

Authors:  Ramnath Nayak; David J Pintel
Journal:  J Virol       Date:  2006-12-13       Impact factor: 5.103

7.  Adeno-associated viruses can induce phosphorylation of eIF2alpha via PKR activation, which can be overcome by helper adenovirus type 5 virus-associated RNA.

Authors:  Ramnath Nayak; David J Pintel
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

8.  Expression of the E3L gene of vaccinia virus in transgenic mice decreases host resistance to vaccinia virus and Leishmania major infections.

Authors:  Elena Domingo-Gil; Eva Pérez-Jiménez; Iván Ventoso; José L Nájera; Mariano Esteban
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

9.  Nuclear transport of trimeric assembly intermediates exerts a morphogenetic control on the icosahedral parvovirus capsid.

Authors:  Laura Riolobos; Juan Reguera; Mauricio G Mateu; José M Almendral
Journal:  J Mol Biol       Date:  2006-01-23       Impact factor: 5.469

Review 10.  Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action.

Authors:  M A García; J Gil; I Ventoso; S Guerra; E Domingo; C Rivas; M Esteban
Journal:  Microbiol Mol Biol Rev       Date:  2006-12       Impact factor: 11.056

View more
  12 in total

Review 1.  Oncolytic virus therapy for glioblastoma multiforme: concepts and candidates.

Authors:  Guido Wollmann; Koray Ozduman; Anthony N van den Pol
Journal:  Cancer J       Date:  2012 Jan-Feb       Impact factor: 3.360

2.  Adaptive changes in alphavirus mRNA translation allowed colonization of vertebrate hosts.

Authors:  Iván Ventoso
Journal:  J Virol       Date:  2012-07-03       Impact factor: 5.103

3.  Antiangiogenic Vascular Endothelial Growth Factor-Blocking Peptides Displayed on the Capsid of an Infectious Oncolytic Parvovirus: Assembly and Immune Interactions.

Authors:  Esther Grueso; Cristina Sánchez-Martínez; Tania Calvo-López; Fernando J de Miguel; Noelia Blanco-Menéndez; Marian Fernandez-Estevez; Maria Elizalde; Jorge Sanchez; Omar Kourani; Diana Martin; Aroa Tato; Milagros Guerra; Germán Andrés; José M Almendral
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

4.  Induction of an embryonic mouse innate immune response following inoculation in utero with minute virus of mice.

Authors:  Irina Rostovsky; Claytus Davis
Journal:  J Virol       Date:  2014-12-03       Impact factor: 5.103

5.  Autonomous parvoviruses neither stimulate nor are inhibited by the type I interferon response in human normal or cancer cells.

Authors:  Justin C Paglino; Wells Andres; Anthony N van den Pol
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

6.  Complementary induction of immunogenic cell death by oncolytic parvovirus H-1PV and gemcitabine in pancreatic cancer.

Authors:  Assia L Angelova; Svitlana P Grekova; Anette Heller; Olga Kuhlmann; Esther Soyka; Thomas Giese; Marc Aprahamian; Gaétan Bour; Sven Rüffer; Celina Cziepluch; Laurent Daeffler; Jean Rommelaere; Jens Werner; Zahari Raykov; Nathalia A Giese
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

7.  Parvovirus evades interferon-dependent viral control in primary mouse embryonic fibroblasts.

Authors:  Lisa M Mattei; Susan F Cotmore; Peter Tattersall; Akiko Iwasaki
Journal:  Virology       Date:  2013-05-12       Impact factor: 3.616

8.  Human Retrotransposons and the Global Shutdown of Homeostatic Innate Immunity by Oncolytic Parvovirus H-1PV in Pancreatic Cancer.

Authors:  Matthias Neulinger-Muñoz; Dominik Schaack; Svetlana P Grekova; Andrea S Bauer; Thomas Giese; Gabriel A Salg; Elisa Espinet; Barbara Leuchs; Anette Heller; Jürg P F Nüesch; Miriam Schenk; Michael Volkmar; Nathalia A Giese
Journal:  Viruses       Date:  2021-05-28       Impact factor: 5.048

9.  GCN2 has inhibitory effect on human immunodeficiency virus-1 protein synthesis and is cleaved upon viral infection.

Authors:  Javier del Pino; José Luis Jiménez; Iván Ventoso; Alfredo Castelló; Ma Ángeles Muñoz-Fernández; César de Haro; Juan José Berlanga
Journal:  PLoS One       Date:  2012-10-23       Impact factor: 3.240

Review 10.  Protoparvovirus Cell Entry.

Authors:  Carlos Ros; Nooshin Bayat; Raphael Wolfisberg; José M Almendral
Journal:  Viruses       Date:  2017-10-26       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.